Mali vs Philippines: HIV/AIDS deaths averted by antiretroviral therapy
Mali
5,460 deaths
in 2024
Philippines
5,500 deaths
in 2024
Mali rank
36th
Philippines rank
34th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Mali
- Philippines
How they compare
Philippines currently reports 5,500 deaths against 5,460 deaths in Mali, a difference of 40 deaths.
The two have swapped places 2 times across 35 shared years of data; in 1990 it was Philippines ahead.
Mali ranks 36th and Philippines ranks 34th of 157 countries.
Mali has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Mali | Philippines | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0 deaths | 0 deaths | — |
| 2000s | 1,193 deaths | 23.06 deaths | 1,170 deaths | Mali |
| 2010s | 3,647 deaths | 1,105 deaths | 2,543 deaths | Mali |
| 2020s | 4,734 deaths | 4,288 deaths | 445.71 deaths | Mali |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Mali or Philippines?
- Philippines, at 5,500 deaths against 5,460 deaths in Mali as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Mali and Philippines?
- 40 deaths, with Philippines ahead.
- How many years of comparable data are there for Mali and Philippines?
- 35 years are reported by both, from 1990 to 2024.
- How do Mali and Philippines rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Mali ranks 36th and Philippines ranks 34th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.